<?xml version="1.0" encoding="UTF-8"?>
<p id="p0150">To follow up on this report, the Brighton Collaboration (a global, non-profit, scientifically independent, group created for the purpose of providing reliable, high quality international information and guidelines relevant to vaccine safety) charged a working group to explore the relevance of recombination to vaccine safety. The working group findings in 2016 
 <xref rid="b0165" ref-type="bibr">[33]</xref> considered examples of, and risks attributed to recombination and reassortment of traditional LAVs and novel, chimeric vectored vaccines. All extant examples of such interactions were cited.
</p>
